|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4174 | |
| A61K 9/08 | |||
| A61K 9/107 | |||
| A61P 25/00 | |||
| A61P 29/00 |
| (11) | Number of the document | 2429521 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10775671.0 |
| Date of filing the European patent application | 2010-05-17 | |
| (97) | Date of publication of the European application | 2012-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/035136 |
| Date | 2010-05-17 |
| (87) | Number | WO 2010/132882 |
| Date | 2010-11-18 |
| (30) | Number | Date | Country code |
| 178730 P | 2009-05-15 | US |
| (72) |
HENWOOD, Geraldine Anne, US
MACK, Randall Jerome, US
SHARR, Christopher Thomas, US
KOLENG, Jr., John Joseph, US
|
| (73) |
Recro Pharma, Inc.,
490 Lapp Road, Malvern PA 19355,
US
|
| (54) | SUBLINGUAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF |
| SUBLINGUAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF |